$UTHR (UNITED THERAPEUTICS) — 8-K: United Therapeutics Board Authorizes New $2 Billion Share Repurchase Program Through October 2027

The Board of Directors authorized a new share repurchase program for up to $2 billion of common stock, available through October 21, 2027. The program may be implemented through accelerated share repurchase programs, open market transactions, privately negotiated transactions or other means. An ongoing accelerated share repurchase transaction entered into in September 2026, scheduled to terminate in the fourth quarter of 2026, will not reduce the amount available under the new authorization.

The Board of Directors authorized a new share repurchase program for up to $2 billion of common stock, available through October 21, 2027. The program may be implemented through accelerated share repu